MedPath

A study on efficacy of Ezetimibe in patients with Dyslipidemia associated with Digestive disease-Its effect on biliary bigly metabolism

Not Applicable
Conditions
hypercholesterolemia
Registration Number
JPRN-UMIN000004183
Lead Sponsor
Hiroshima University hospital Department of General Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who are treated with insulin 2)HbA1>=8% 3)History ofhypersensitivity to Ezetimibe 4)Serious hepatic disfunctions 5)Patient whom biliary tract comletely blockaded 6)Serious kidney disfunctions 7)AMI,angina and stroke within 3 months before intervention 8)Secondary hypercholesterolemia or medical hypercholesterolemia 9)Pregnant or lactating women and women who may be pregnant 10)Familial hypercholesterolemia 11)Bronchial Asthma or an allergic disease 12)Judged by investigator not to be appropriate for inclusion in this study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Before and after 6 months of Ezetimibe to clinical effectiveness and bile composition
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath